Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study-Reference-Cited by-同舟云学术

Linagliptin monotherapy provides superior glycaemic control versus placebo or voglibose with comparable safety in Japanese patients with type 2 diabetes: a randomized, placebo and active comparator-controlled, double-blind study

Published:2012-01-17 Issue:4 Volume:14 Page:348-357
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:

Author:

Kawamori R.,Inagaki N.,Araki E.,Watada H.,Hayashi N.,Horie Y.,Sarashina A.,Gong Y.,von Eynatten M.,Woerle H. J.,Dugi K. A.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1463-1326.2011.01545.x/fullpdf

Reference30 articles.

1. Japanese Ministry of Health Labour and Welfare. The National Health and Nutrition Survey 2007. http://www.mhlw.go.jp/houdou/2008/12/h1225-5.html

2. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.;Turner;JAMA,1999

3. Current issues in the treatment of type 2 diabetes. Overview of newer agents: where treatment is going.;DeFronzo;Am J Med,2010

4. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).;Yokoyama;Nephrol Dial Transplant,2009

5. Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes.;Yokoyama;Kidney Int,2000

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety of Linagliptin in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Clinical Trials;Therapeutic Innovation & Regulatory Science;2024-04-18

2. Biochemical and computational inhibition of α-glucosidase by novel metronidazole-linked 1 H -1,2,3-triazole and carboxylate moieties: kinetics and dynamic investigations;Journal of Biomolecular Structure and Dynamics;2024-03-03

3. Choice of Glucose-Lowering Drugs as Initial Monotherapy for Type 2 Diabetes Patients with Contraindications or Intolerance to Metformin: A Systematic Review and Meta-Analysis;Journal of Clinical Medicine;2022-11-30

4. Use of Antihyperglycemic Drugs and Risk of Cancer in Patients with Diabetes;Current Oncology Reports;2022-11-29

5. Dipeptidyl peptidase-4 inhibitors and gallbladder or biliary disease in type 2 diabetes: systematic review and pairwise and network meta-analysis of randomised controlled trials;BMJ;2022-06-28